Pfizer to launch cheaper version of J&J immune drug Remicade

Drugmaker Pfizer says next month it will launch a less-expensive version of rival Johnson & Johnson's blockbuster immune disorder drug, Remicade. Pfizer Inc.'s version, called Inflectra, will hit pharmacies ...